Effects of Compound Milk Oligosaccharides on Growth Performance, Immune Function, and Intestinal Health of Neonatal Suckling Piglets with Different Birth Weights.
- 1Key Laboratory of Animal Disease-Resistance Nutrition, Institute of Animal Nutrition, Sichuan Agricultural University, No. 211 Huimin Road, Wenjiang District, Chengdu 611130, China.
- 2Sichuan Chiyang Agricultural Development Co., Ltd., Room 2101, Floor 21, Unit 1, Building 3, No. 722, Middle Section of Yizhou Avenue, China (Sichuan) Pilot Free Trade Zone, Chengdu High-Tech Zone, Chengdu 610041, China.
Abstract
This experiment was conducted to investigate the effects of compound milk oligosaccharides (CMO) on growth performance, immune function, and intestinal health of neonatal suckling piglets with different birth weights. Forty neonatal suckling piglets (20 piglets with normal birth body weight (NBW), 20 piglets with low birth body weight (LBW)) from 10 lactating sows with the same parity and litter size (2 normal birth weight piglets and 2 low birth weight piglets from each sow), were allotted to one of four treatments (10 replications with 1 piglet per treatment) in a 2 × 2 factorial design, including two birth body weight (normal or low birth weight) and two CMO doses (0 or 75 mg/d). All piglets were orally administered 2 mL CMO solution (37.5 mg/mL CMO, with a ratio of 3' SL:2' FL:6' SL = 5:4:1) or equivalent volume saline daily, from birth until day 21 of age. At the end of the trial, eight piglets per treatment were used for terminal serum and intestinal measurements, and five piglets per treatment were used for colonic microbiota analysis. As expected, NBW piglets had higher body weight and average daily gain than LBW littermates (p < 0.05), accompanied by a lower colonic abundance of Escherichia-Shigella (p < 0.05). More importantly, oral CMO administration from birth to weaning improved body weight on days 14 and 21, average daily gain, jejunal villus height, and the villus height-to-crypt depth ratio, decreased serum IL-1β, IL-6, and IL-10 concentrations, and inhibited ileal mRNA expression of IL-1β and MyD88 in piglets of both birth weight groups. In addition, CMO markedly downregulated ileal NF-κB expression in LBW piglets (p < 0.05). Interaction analysis indicated that the interaction between birth weight and CMO supplementation specifically decreased ileal TLR4 gene expression, reduced colonic observed species, Chao 1 and ACE indices, and enriched colonic Parabacteroides in LBW piglets (p < 0.05). In summary, these findings demonstrated that a daily oral dose of 75 mg CMO improved growth performance and intestinal health in suckling piglets, and the underlying mechanisms may be closely associated with alleviation of intestinal inflammation, improvement of intestinal morphology, and modulation of gut microbial balance.
Related
- Effects of maternal supplementation with fatty acid-balanced oil on the performance of sows and intestinal barrier function of offspring
- Effects of different copper sources on performance, carcass characteristics and intestinal histomorphology in broiler chickens
- Comparative Effects of Different Dietary Acidifiers on Growth Performance and Intestinal Health in Weaned Piglets.
- Heat stress triggers bone performance degeneration via impairing intestinal barrier function and altering gut microbiota in chickens.
- Effects of Partial Replacing Fish Meal with Dietary Degossypolled Cottonseed Protein on Growth Performance, Intestinal Barrier, Immune Function and Antioxidant Response in Largemouth Bass (Micropterus salmoides).
BibTeX
@article{zhang2026effects,
title = {{Effects of Compound Milk Oligosaccharides on Growth Performance, Immune Function, and Intestinal Health of Neonatal Suckling Piglets with Different Birth Weights.}},
author = {Peng Zhang and Gang Tian and Daiwen Chen and Junning Pu and Ping Zheng and Jie Yu and Bing Yu},
journal = {Animals : an open access journal from MDPI},
year = {2026},
month = oct,
doi = {10.3390/ani16193150},
url = {https://europepmc.org/article/MED/42883119},
note = {CC BY},
}
RIS
TY - JOUR
TI - Effects of Compound Milk Oligosaccharides on Growth Performance, Immune Function, and Intestinal Health of Neonatal Suckling Piglets with Different Birth Weights.
AU - Peng Zhang
AU - Gang Tian
AU - Daiwen Chen
AU - Junning Pu
AU - Ping Zheng
AU - Jie Yu
AU - Bing Yu
PY - 2026
DA - 2026/10/08
JO - Animals : an open access journal from MDPI
DO - 10.3390/ani16193150
UR - https://europepmc.org/article/MED/42883119
AB - This experiment was conducted to investigate the effects of compound milk oligosaccharides (CMO) on growth performance, immune function, and intestinal health of neonatal suckling piglets with different birth weights. Forty neonatal suckling piglets (20 piglets with normal birth body weight (NBW), 20 piglets with low birth body weight (LBW)) from 10 lactating sows with the same parity and litter size (2 normal birth weight piglets and 2 low birth weight piglets from each sow), were allotted to one of four treatments (10 replications with 1 piglet per treatment) in a 2 × 2 factorial design, including two birth body weight (normal or low birth weight) and two CMO doses (0 or 75 mg/d). All piglets were orally administered 2 mL CMO solution (37.5 mg/mL CMO, with a ratio of 3' SL:2' FL:6' SL = 5:4:1) or equivalent volume saline daily, from birth until day 21 of age. At the end of the trial, eight piglets per treatment were used for terminal serum and intestinal measurements, and five piglets per treatment were used for colonic microbiota analysis. As expected, NBW piglets had higher body weight and average daily gain than LBW littermates (p < 0.05), accompanied by a lower colonic abundance of Escherichia-Shigella (p < 0.05). More importantly, oral CMO administration from birth to weaning improved body weight on days 14 and 21, average daily gain, jejunal villus height, and the villus height-to-crypt depth ratio, decreased serum IL-1β, IL-6, and IL-10 concentrations, and inhibited ileal mRNA expression of IL-1β and MyD88 in piglets of both birth weight groups. In addition, CMO markedly downregulated ileal NF-κB expression in LBW piglets (p < 0.05). Interaction analysis indicated that the interaction between birth weight and CMO supplementation specifically decreased ileal TLR4 gene expression, reduced colonic observed species, Chao 1 and ACE indices, and enriched colonic Parabacteroides in LBW piglets (p < 0.05). In summary, these findings demonstrated that a daily oral dose of 75 mg CMO improved growth performance and intestinal health in suckling piglets, and the underlying mechanisms may be closely associated with alleviation of intestinal inflammation, improvement of intestinal morphology, and modulation of gut microbial balance.
SN - 2076-2615
ER -